We would love to hear your thoughts about our site and services, please take our survey here.
okay, then let's wait and see - antibodies, etc.. how much we talking here - 2/3/4 times rise? do not consider this to be a big deal. pharma crazy rises is over IMO.
Now is the time to go back to the old favourites. if you are expecting big rise here, you might just go for FCCN and EZJ stock to triple this month.. that's just me
virus is miraculously disappearing according to the BBC news yesterday report which said vaccine development is not only against virus but the time too!! so not only test kits, vaccine won't be needed. multiple bags here?? unlikely. this funny talk has been here for weeks with NRS, etc. Every Friday I read - NRS and we will sky rocket, sounds like a hope only!
its clear and unavoidable.
lots of post here talking about 'the dream land' of 20 an 50p, it aint happening.
unless they recreate anti-SARS-CoV-2 virus antibodies to treat COVID-19 - that's it and stop ****ging each other. let those who believe - believe, that what this game is about and those who don't - they have right not to.
every pharma now competes and this is not the reason to be fooled and pump sh.t loads of cash in here and very unlikely they will create one as in the past there was no vaccine for SARS and MERS (only for Ebola made by CanSino which is Chinese pharma)
me personally thinking it's going back to 3-4p with its prime focus on leukemia and G.d knows when those break through will be happening to reach back 14p at least, so few years to hold, if not few decades
someone here mentioned a big contract from the government with relations to the COVID 19. it nothing like this, if only covid delays their new software development so I have commented on that and disagreed about the 'big foolish hopes' for another skyrocket rally. Seems like every pharma out there is being linked to the test kits and vaccine, fam is desperate for another NCYT or Valirx. Please read below latest statement:
The study is for further development of and evidence generation for a precision dosing tool for optimising chemotherapy dosing in advanced prostate cancer. Physiomics expects it to delay due to the measures being taken by all hospitals in the UK to minimise non-Covid-19 related activity
If you on the hunt for another big rally dog, check CANSINO Biologics
Tue big day !
Our Virtual Tumour™ platform is one of the industry’s most advanced predictive models focused solely on oncology, predicting optimal drug dosing, scheduling and combinations.
since 2015 the shares were rally 10 to 1, then again 10 to 1 - same model I see here
anyway, lets wait and see... COVID won't make each every pharma out there NCYT example imo
I cannot see big contract landing here with COVID situation, primarily PYC is a cancer research and drug developer company and how many of them out there... it had its moment nice way to 11p and now slowly back to it's steady 2.5. I tried to get in early but it wont let me, so got in at the peak point and now I m on -60%. so only miracle would solve this problem otherwise long long wait till the better times come
all they have done is cut their losses, balance sheet is even, he made his share and he is out... maybe he knows big revenues won't be coming in. it will take at least next Q2 results and then G.d knows how long to wait
UK-based global mobile media company Mobile Streams confirmed that the legacy mobile content business continues to perform in line with expectations. Group revenue for Q1 2010 was GBP 100,000, down from GBP 190,000 a year earlier.
In a trading update, Mobile Streams said that EBITDA for the quarter showed a loss of GBP 131,000, compared to a loss of GBP 479,000 in Q1 2019. This improvement was attributed to cost cutting measures implemented across the group. Revenue in Argentina and Mexico remained stable in Q1, and the underlying operations of the existing mobile content business are running at almost break-even, despite lower revenues year-on-year.
The group cash balance is currently at GBP 97,000, including the net proceeds of the GBP 75,000 placing announced at end-March, and a net tax credit of GBP 50,000 received in March by the Argentine business.
Mobile Streams also said that the Streams platforms delivered through a partnership with KrunchData continues to perform well, with positive feedback on the platform from the National Emergencies Trust (NET), which is using Streams to support its pandemic work. This feedback has led to Mobile Streams signing an additional contract with digital agency Alcimi for delivery of insight and intelligence services, with work on this agreement already underway.
Mobile Streams PLC’s (LON:MOS) shares jumped 11% higher to 0.31p in early trade on Tuesday after the group said it has signed a data-sharing agreement with the National Emergencies Trust (NET).
The agreement will provide data insight, intelligence and visualisation services to the UK charity responsible for the collection and distribution of funds in response to the coronavirus (COVID-19) pandemic.
The AIM-listed company's 'Streams' platform and services are helping to inform and assist the NET in a number of areas including assessing the impact and spread of the pandemic as well as identifying the sectors, industries and people most affected and in need of funding, Mobile Streams said.
Greatland Gold plc with EPIC/TICKER (LON:GGP) 0 has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Numis. Greatland Gold plc are listed in the Basic Materials sector within AIM. Numis have set a target price of 12 GBX on its stock. This indicates the analyst now believes there is a potential upside of 26.6% from the opening price of 9.48 GBX.
remember that old Guinness advert - GOOD THINGS COME TO THOSE WHO WAIT https://en.wikipedia.org/wiki/Good_things_come_to_those_who_wait_(Guinness)#/media/File:Goodthingsshot.jpg